AXNX News and Press, Axonics Modulation Technologies Inc. From 01/21/20

Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (SNM) devices for the treatment of bladder and bowel dysfunction, today announced U.S. Food & Drug Administrati...

After management offered an early look at the company's fourth-quarter financial results, Axonics Modulation Technologies (NASDAQ: AXNX) shares are rocketing 24.5% higher at 1:00 p.m. EST on Thursday. Axonics secured Food and Drug Administration approval to begin marketing its implantable t...

Gainers: Trillium Therapeutics (NASDAQ: TRIL ) +106% . More news on: Trillium Therapeutics Inc., Applied Genetic Technologies Corporation, Genetic Technologies Limited, Stocks on the move, Read more ...

Applied Genetic Technologies (NASDAQ: AGTC ) +53%  on positive XLRP data . More news on: Applied Genetic Technologies Corporation, VBI Vaccines Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...

Axonics Modulation Technologies (NASDAQ: AXNX ) has reported preliminary Q4 and FY 2019 revenue. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Read more ...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today reported preliminary unaud...

Agilent (NYSE: A ) initiated with Overweight rating and $100 (18% upside) price target at Wells Fargo. More news on: Agilent Technologies, Inc., Avantor, Inc., Axonics Modulation Technologies, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

The USPTO has issued or allowed Axonics Modulation Technologies (NASDAQ: AXNX ) nine U.S. utility patents in 2019, along with numerous foreign counterparts relating to its implantable sacral neuromodulation technology. More news on: Axonics Modulation Technologies, Inc., Healthcare stock...

Seven Additional Patents Granted in Western Europe, Japan, China, Australia and Canada Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), (“Axonics”), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today...